Innovent Biologics Inc. has announced the grant of 20,800 share options and restricted shares to five grantees, including independent non-executive Director Dr. Sherwin, as part of their 2024 Share Scheme. The company aims to align the interests of its key personnel with its strategic goals. Notably, the restricted shares granted to Dr. Sherwin come without performance targets, reflecting the company's commitment to maintaining the independence and objectivity of its independent directors. The announcement was made on August 29, 2025, by Dr. De-Chao Michael Yu, Chairman and Executive Director of Innovent Biologics.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.